Skip to main content
Top
Published in: Clinical Rheumatology 8/2007

01-08-2007 | Case report

Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab

Authors: M. Mubashir Ahmed, Eisha Mubashir, Neville R. Dossabhoy

Published in: Clinical Rheumatology | Issue 8/2007

Login to get access

Abstract

Sarcoidosis is a multisystem disease characterized by noncaseating granulomatous reaction frequently involving the lymph nodes, lungs, liver, skin, and eyes. Acute renal failure (ARF) as an isolated manifestation of sarcoidosis is rare. We describe a case of sarcoidosis presenting as transient polyarthritis and ARF due to isolated granulomatous infiltration of the renal parenchyma. Renal biopsy showed granulomatous interstitial nephritis with noncaseating granulomas consistent with sarcoidosis. Bacterial, fungal, and mycobacterial infections were excluded. There was no evidence of extrarenal sarcoid involvement. Prednisone of 60 mg daily resulted in significant improvement in renal function. Because of recurrent flares on steroid taper and steroid toxicity, treatment with infliximab, an anti-tumor necrosis factor-α (TNF-α) antibody, was instituted and resulted in stabilization of renal function despite steroid taper. Although uncommon, renal sarcoidosis should be considered in the differential diagnosis of acute or chronic renal failure of uncertain etiology, as early diagnosis and treatment can lead to recovery of renal function and prevent interstitial fibrosis. Corticosteroids are mainstay of therapy. Steroid-dependant or refractory cases may respond to other immunosuppressants including anti-TNF-α agents.
Literature
1.
go back to reference Johns CJ, Michele TM (1999) The clinical management of sarcoidosis. A 50-year experience at the John Hopkins Hospital. Medicine 78:65–111PubMedCrossRef Johns CJ, Michele TM (1999) The clinical management of sarcoidosis. A 50-year experience at the John Hopkins Hospital. Medicine 78:65–111PubMedCrossRef
2.
go back to reference Roach DR, Bean AG, Demangel C et al (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620–4627PubMed Roach DR, Bean AG, Demangel C et al (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620–4627PubMed
3.
go back to reference Longcope WT, Freiman DG (1952) A study of sarcoidosis based upon a combined investigation of 160 cases including 30 autopsies from John Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 31:1CrossRef Longcope WT, Freiman DG (1952) A study of sarcoidosis based upon a combined investigation of 160 cases including 30 autopsies from John Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 31:1CrossRef
4.
go back to reference Ricker W, Clark M (1949) Sarcoidosis: a clinicopathologic review of 300 cases, including 22 autopsies. Am J Clin Pathol 19:725–749PubMed Ricker W, Clark M (1949) Sarcoidosis: a clinicopathologic review of 300 cases, including 22 autopsies. Am J Clin Pathol 19:725–749PubMed
5.
go back to reference Meyrier A (2001) Sarcoidosis: the nephrologist’s view. Ann Med Interne (Paris) 152(1):45–50 (Review) (Feb) Meyrier A (2001) Sarcoidosis: the nephrologist’s view. Ann Med Interne (Paris) 152(1):45–50 (Review) (Feb)
6.
go back to reference Libacq E, Verhaegen H, Desment V (1970) Renal involvement in sarcoidosis. Postgrad Med J 46:526–529 Libacq E, Verhaegen H, Desment V (1970) Renal involvement in sarcoidosis. Postgrad Med J 46:526–529
7.
go back to reference Berger KW, Relman AS (1955) Renal impairment due to sarcoid infiltration of the kidney: report of a case proven by renal biopsies before and after treatment with cortisone. N Engl J Med 252:44–49PubMedCrossRef Berger KW, Relman AS (1955) Renal impairment due to sarcoid infiltration of the kidney: report of a case proven by renal biopsies before and after treatment with cortisone. N Engl J Med 252:44–49PubMedCrossRef
8.
go back to reference Bear RA, Handelsman S, Lang A et al (1979) Clinical and pathological features of six cases of sarcoidosis presenting with renal failure. Can Med Assoc J 121(10):1367–1371 (Nov 17)PubMed Bear RA, Handelsman S, Lang A et al (1979) Clinical and pathological features of six cases of sarcoidosis presenting with renal failure. Can Med Assoc J 121(10):1367–1371 (Nov 17)PubMed
9.
go back to reference Williams PF, Thomason D, Anderton JL (1984) Reversible renal failure due to isolated renal sarcoidosis. Nephron 37(4):246–249PubMedCrossRef Williams PF, Thomason D, Anderton JL (1984) Reversible renal failure due to isolated renal sarcoidosis. Nephron 37(4):246–249PubMedCrossRef
10.
go back to reference Verani R, Nasir M, Foley R (1989) Granulomatous interstitial nephritis after a jejunoileal bypass: an ultrastructural and histochemical study. Am J Nephrol 9(1):51–55PubMed Verani R, Nasir M, Foley R (1989) Granulomatous interstitial nephritis after a jejunoileal bypass: an ultrastructural and histochemical study. Am J Nephrol 9(1):51–55PubMed
11.
go back to reference Sweiss NJ, Welsch MJ, Curran JJ, Ellman MH (2005) Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis. Arthritis Rheum 53(5):788–791 (Oct 15)PubMedCrossRef Sweiss NJ, Welsch MJ, Curran JJ, Ellman MH (2005) Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis. Arthritis Rheum 53(5):788–791 (Oct 15)PubMedCrossRef
Metadata
Title
Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab
Authors
M. Mubashir Ahmed
Eisha Mubashir
Neville R. Dossabhoy
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 8/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0357-4

Other articles of this Issue 8/2007

Clinical Rheumatology 8/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine